PMID: 42307498

Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity.

Everett Brendan M, Ostrominski John W

Journal of the American College of Cardiology · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.